Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × pamiparib × Sarcoma × Clear all

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1

Conditions

Ovarian Neoplasms 1 Carcinosarcoma 1

Interventions

Cyclophosphamide 9 Radiotherapy 7 pazopanib 5 Temozolomide 5 Magnetic Resonance Spectroscopy 5 Filgrastim 5 Doxorubicin 5 pembrolizumab 4 Vincristine 4 Gemcitabine 4 Etoposide 4 Docetaxel 4 Carboplatin 4 Biopsy 4 Taxes 3 Specimen Handling 3 Radiation 3 Paclitaxel 3 Nivolumab 3 Irinotecan 3 Drug Therapy 3 olaparib 2 niraparib 2 liposomal doxorubicin 2 fludarabine phosphate 2 fludarabine 2 brigimadlin 2 Trastuzumab 2 Trabectedin 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03933761 2021-08-10

PRECISE

Australia New Zealand Gynaecological Oncology Group

Phase 2 Withdrawn

GynecologicSarcoma

Carcinosarcoma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡